1. Home
  2. GENC vs DTIL Comparison

GENC vs DTIL Comparison

Compare GENC & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gencor Industries Inc.

GENC

Gencor Industries Inc.

HOLD

Current Price

$15.01

Market Cap

219.1M

Sector

Industrials

ML Signal

HOLD

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

HOLD

Current Price

$6.57

Market Cap

185.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GENC
DTIL
Founded
N/A
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
219.1M
185.3M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
GENC
DTIL
Price
$15.01
$6.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$17.60
$45.00
AVG Volume (30 Days)
29.6K
336.5K
Earning Date
02-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
8.08
N/A
EPS
0.50
N/A
Revenue
$48,943,000.00
$1,070,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$25.51
N/A
P/E Ratio
$29.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.22
$3.53
52 Week High
$17.40
$8.82

Technical Indicators

Market Signals
Indicator
GENC
DTIL
Relative Strength Index (RSI) 50.00 46.84
Support Level $14.57 $6.39
Resistance Level $15.62 $7.96
Average True Range (ATR) 0.47 0.57
MACD 0.03 -0.03
Stochastic Oscillator 47.33 28.50

Price Performance

Historical Comparison
GENC
DTIL

About GENC Gencor Industries Inc.

Gencor Industries Inc and its subsidiaries are a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company's products are manufactured in the United States and sold through a combination of Company sales representatives and independent dealers and agents. The Company has one reporting segment, equipment for the highway construction industry. The Company's principal core products include asphalt pavers, hot mix asphalt plants, combustion systems, and fluid heat transfer systems. It operates in the United States, Canada, and other foreign countries, with the majority of revenue coming from the United States.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Share on Social Networks: